Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 5/2009

01-03-2009 | Letter to the Editor

Serum and bronchoalveolar lavage fluid nitric oxide levels in diffuse systemic sclerosis

Authors: Vedat Inal, Kenan Aksu, Gursel Cok, Ferhan Girgin, Gokhan Keser, Fatma Kutay, Eker Doganavsargil

Published in: Rheumatology International | Issue 5/2009

Login to get access

Excerpt

Dear Sir, …
Literature
1.
Takehara K (2003) Pathogenesis of systemic sclerosis. J Rheumatol 30:755–759PubMed
2.
Lotz M (2003) Neuropeptides, free radicals and nitric oxide. In: Hochberg, Silman, Smolen, Weinblatt, Weismann (eds) Rheumatology, 3rd edn, vol 1. Mosby, Philadelphia, pp 135–146
3.
Failli P, Palmieri L, D’Alfonso C et al (2002) Effect of N-acetyl-l-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis. Nitric Oxide 7:277–282PubMedCrossRef
4.
Allanore Y, Borderie D, Hilliquin P et al (2001) Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells. Rheumatology (Oxford) 40:1089–1096CrossRef
5.
Kharitonov SA, Cailes JB, Black CM, du Bois RM, Barnes PJ (1997) Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 52:1051–1055PubMedCrossRef
6.
Fajac I, Kahan A, Menkès CJ et al (1998) Increased nitric oxide in exhaled air in patients with systemic sclerosis. Clin Exp Rheumatol 16:547–552PubMed
7.
Takagi K, Kawaguchi Y, Hara M et al (2003) Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features. Clin Exp Immunol 134:538–544PubMedCrossRef
8.
Tiev KP, Cabane J, Aubourg F et al (2007) Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide. Eur Respir J 30:26–30PubMedCrossRef
9.
Masi AT, Rodnan GP, Medsger TA (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Asociation Diagnostic and Therapeutic Criteria Committee. Arthritis Rheumatism 23:581–590CrossRef
10.
Yamamoto T, Katayama I, Nishioka K (1998) Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 25:314–317PubMed
Metadata
Title
Serum and bronchoalveolar lavage fluid nitric oxide levels in diffuse systemic sclerosis
Authors
Vedat Inal
Kenan Aksu
Gursel Cok
Ferhan Girgin
Gokhan Keser
Fatma Kutay
Eker Doganavsargil
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0729-y

Other articles of this Issue 5/2009

Rheumatology International 5/2009 Go to the issue

Original Article

Intracellular calcium responses to cholinergic stimulation of lymphocytes from healthy donors and patients with rheumatoid arthritis

Original Article

Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus

Review

Prevalence of rheumatic diseases and disability in China

Original Article

Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation

Original Aricle

Impact of sex, age, body mass index and handedness on finger joint space width in patients with prolonged rheumatoid arthritis using computer-aided joint space analysis

Case Report

Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits